Table 1 Demographic characteristics
Treatment success N=116 | Treatment failure n=14 | P values | |
|---|---|---|---|
Age | 63 (27, 84) | 60 (24, 76) | 0.942 |
Female (n, %) | 68, 58.62% | 5, 35.71% | 0.103 |
Knee (n, %) | 49, 42.24% | 8, 57.14% | 0.288 |
BMI* | 23.95 (16.6, 36.49) | 28.72 (22.1, 28.7) | 0.108 |
ASA | |||
2 | 63, 54.31% | 10, 71.42% | 0.223 |
3 | 6, 5.17 % | 0 | 1 |
4 | 0 | 0 | 1 |
Liver disease(n,%) | 3, 2.59% | 0 | 1 |
Kidney disease(n,%) | 1, 0.86% | 0 | 1 |
Heart disease(n,%) | 9, 7.76% | 1, 7.14% | 1 |
DM(n,%) | 19, 16.38% | 0 | 1 |
Inflammatory joint diseases (n,%) | 6, 5.17% | 1, 7.14% | 1 |
Spacer interval(day)* | 120.5 (32, 535) | 144 (52, 308) | 0.47 |
Causative pathogens | |||
CNS | 50, 43.10% | 2, 14.29% | 0.038 |
Staphylococcus aureus | 7, 6.03% | 4, 28.57% | 0.019 |
Enterococcus spp. | 5, 4.31% | 0 | 1 |
Streptococcus spp. | 8, 6.90% | 1, 7.14% | 1 |
Gram-negative bacteria | 10, 8.62% | 4, 28.57% | 0.045 |
Fungi | 5, 4.31% | 0 | 1 |
Other pathogens | 6, 5.26% | 1, 7.14% | 0.559 |
Culture negative | 40, 34.48% | 3, 21.43% | 0.385 |